MECHANISMS OF RESISTANCE TO ANDROGEN DEPRIVATION THERAPY IN ADVANCED CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

Beth Israel Deaconess Medical Center, Inc.

Investigators